Midcap Picks with Anil Singhvi: KSB Pumps, Borosil Ltd, Ajanta Pharma are stocks to buy for bumper returns

In conversation with Zee Business Managing Editor Anil Singhvi on the Special Midcap Stock Picks show, market expert Siddharth Sedani recommended three stocks to investors. Sedani picked KSB Pumps, Borosil Ltd and Ajanta Pharma with long, positional, and short-term views respectively. Here is why this expert picked these shares:  

Long Term Pick: KSB Pumps 

A multi-national company, whose roots are in Germany, Siddharth Sedani is quite bullish on KSB Pumps, he suggests to Buy the shares of the company for a target of Rs 1177 apiece for the long term.  

See Zee Business Live TV Streaming Below:

He explains, the quarter four results of the company have been spectacular with 50 per cent rise in revenue, similarly, its EBITDA Margins have doubled in the March-ended quarter by 16 per cent versus seven per cent a year-on-year basis. 

He expects, there is going to be a splendid pick-up in the order book of KSB Pumps in the next two to three years. It has a strong parentage, execution wise it has very good abilities, they have recently received orders of reactors, adds the expert. 

शॉर्ट टर्म, पोजीशनल और लॉन्ग टर्म में सिद्धार्थ सेडानी ने किन मिडकैप शेयरों में बनेगा पैसा? #SPLMidcapStocks @AnilSinghvi_ @s_sedani05 pic.twitter.com/YU1TLHAqIq

— Zee Business (@ZeeBusiness) May 6, 2021

Positional Pick: Borosil Ltd 

A consumer and life-science product manufacturer, Borosil Ltd is a market leader with a 30-35 per cent market share, says Sedani. He adds, the company makes vials for the vaccine doses, which likely to be used in the covid vaccine storage process.  

Borosil has a very good name in the volumetric glass segment such as pharma, R&D and scientific labs, school labs, and all other glass lab equipment category, the market expert says while explaining the splendid fundamentals of Borosil. He sets a target price of Rs 251 per share in a positional view. 

Short Term Pick: Ajanta Pharma 

Sedani’s short-term mid-cap pick is a leader in manufacturing generic drugs – Ajanta Pharma. India has a prominent name in the world for being largest generic drugs manufacturer. This pharma company’s growth is expected two-three per cent higher than the whole industry going forward. The market expert expects the stock to grow at Rs 2167 per share in the next one to three months.